MARKET

JUNS

JUNS

JUPITER NEUROSCIENCES, INC.
NASDAQ
1.140
-0.080
-6.56%
After Hours: 1.120 -0.02 -1.75% 19:40 12/05 EST
OPEN
1.210
PREV CLOSE
1.220
HIGH
1.222
LOW
1.130
VOLUME
37.10K
TURNOVER
--
52 WEEK HIGH
19.51
52 WEEK LOW
0.5100
MARKET CAP
39.25M
P/E (TTM)
-4.9652
1D
5D
1M
3M
1Y
5Y
1D
Vanguard Total Stock Market ETF (VTI) Daily Update—12/04/25
TipRanks · 3d ago
Jupiter Neurosciences CEO says entering 2026 with ‘momentum, clarity’
TipRanks · 4d ago
VTI ETF Daily Update—12/03/2025
TipRanks · 4d ago
Jupiter Neurosciences to Present at NobleCon21 Emerging Growth Conference
Reuters · 5d ago
VTI ETF Daily Update—12/02/25
TipRanks · 5d ago
VTI ETF Daily Snapshot—12/01/2025
TipRanks · 6d ago
Weekly Report: what happened at JUNS last week (1124-1128)?
Weekly Report · 6d ago
Jupiter Neurosciences Files Prospectus Related To Resale Of Up To 10M Shares Of Our Common Stock By Selling Stockholder
Benzinga · 11/26 22:31
More
About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Webull offers Jupiter Neurosciences Inc stock information, including NASDAQ: JUNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JUNS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JUNS stock methods without spending real money on the virtual paper trading platform.